Portrays the Cabinet directive as a restrictive policy that impedes evidence-based medical recommendations.
The article presents the directive as a top-down constraint that prevents expert networks from formally objecting to policy changes, framing it as an overreach that misinterprets international law to block clinical input.
“They have interpreted a Cabinet directive as that we cannot submit concerns to Pharmac on the basis of ethnicity.”
